EMA Reflects on Coated Nanomedicines - - BioPharm International

ADVERTISEMENT

EMA Reflects on Coated Nanomedicines


The European Medicines Agency (EMA) has published a reflection paper on general issues regarding the development of coated nanomedicines. The paper addresses issues that may arise in the development of nanomedicines that have a coating, including the effect of the coating on stability and possible interactions with other molecules.

The reflection paper is one in a series of four guidance documents discussing nanomedicines. EMA’s Committee for Medicinal Products for Human Use began developing guidance on the development of new nanomedicines and nanosimilars in 2011.

Source: European Medicines Agency

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

NIH Launches Human Safety Study of Ebola Vaccine Candidate
August 29, 2014
Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
USP Awards Analytical Research
August 15, 2014
Author Guidelines

Click here